by PRI | Jun 17, 2022 | Microbiome Clinical Research (CRO)
We are a world-class provider of human clinical studies. We perform acute, observational, PK/PD, pivotal, efficacy, and intervention studies to ICH-GCP standards for microbiome products. ...
by PRI | Jun 17, 2022 | Microbiome Product Developer
Nail Nasir Scientific Manager Astel Medica is a fast growing belgian pharmaceutical company. Founded in 1988 with the collaboration of the University of Liège, Astel Medica is the Belgian leader in the conception and manufacturing of innovative evidence based...
by PRI | Jun 17, 2022 | News & Events
On 13 June 2022 the EU-Innovation Network (jointly coordinated by the European Medicines Agency – EMA, and the Heads of Medicines Agencies – HMA) published a Horizon Scanning Report on Faecal Microbiota Transplantation. The report describes the use of...
by PRI | Jun 11, 2022 | News & Events
Following our announcement in February that we were recruiting a new member to the PRI Staff, we are pleased to announce that Dr. Julie Rodriguez (PhD) accepted to join the PRI as our new OMICS Project Manager. Julie Rodriguez obtained her PhD degree in Physiology,...
by PRI | Jun 9, 2022 | Consumer Goods
Francois Bidet Vice-President of Business Development Aptar CSP Technologies provides highly engineered packaging solutions to meet Probiotics stability needs. Through our Activ-Polymer, moisture and/or oxygen levels are reduced allowing a longer shelflife....
